TherapeuticsMD, Inc. (TXMD) insider trading

By person

21 insiders · 125 transactions

0.2×

Marlan D. Walker holds only 0.2 times base salary in stock. $123.00K of shares against $500.00K in salary for 2024.

Salary from the company's own proxy. The shares are what Marlan D. Walker last reported holding, valued at $1.67, the price Common Stock was last bought or sold at on the open market here, on 23 Dec 2025.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Milligan John C.K. IV

Secretary/CEO of subsidiary

$472.70K (4)

$10.80M (17) scheduled

−$10.32M

5,335,076

46.09%

$8.91M

−1.1%

Rubric Capital Management LP entity

Director

$29.67M (9)

$38.66M (1)

−$8.98M

2,946,908

25.46%

$4.92M

+174.3%

Bernick Brian

Co-Chief Executive Officer

$127.70K (2)

$7.90M (18) scheduled

−$7.78M

6,567,243

56.74%

$10.97M

−2.1%

Finizio Robert G

CEO

$549.98K (7)

$7.72M (17) scheduled

−$7.17M

19,991,637

—

$33.39M

−2.0%

Collins Cooper C.

Director

$1.52M (8)

—

+$1.52M

60,516

0.5228%

$101.08K

—

Krassan Mitchell

Chief Strategy Officer

—

$676.92K (1) scheduled

−$676.92K

0.0000%

$0.00

—

Cartwright Daniel A

Chief Financial Officer

—

$376.80K (2) scheduled

−$376.80K

40,000

0.3456%

$66.81K

0.0%

Thompson Tommy G

Director

$145.37K (10)

—

+$145.37K

25,181

0.2176%

$42.06K

—

Russell Angus C.

Director

$126.60K (3)

—

+$126.60K

5,792

0.0500%

$9.67K

—

MUSING JULES A.

Director

—

$100.92K (1)

−$100.92K

4,022

0.0347%

$6.72K

—

Bisaro Paul

Director

$96.50K (2)

—

+$96.50K

5,922

0.0512%

$9.89K

—

DArecca James

Chief Financial Officer

—

$81.20K (1)

−$81.20K

123,830

1.07%

$206.83K

—

Walker Marlan D

Chief Executive Officer

$2.48K (3)

$75.60K (5)

−$73.12K

73,639

0.6362%

$123.00K

—

BORKOWSKI EDWARD

EVP, Operations

—

$46.02K (1)

−$46.02K

59,248

0.5119%

$98.96K

—

Donegan Michael C

Prin. Fin. and Acctg. Officer

—

$40.94K (7) scheduled

−$40.94K

61,853

0.5344%

$103.31K

—

Ling Karen

Director

$25.08K (1)

—

+$25.08K

4,591

0.0397%

$7.67K

—

Naughton Gail K

Director

—

$20.64K (1)

−$20.64K

8,500

0.0734%

$14.20K

—

Barlow Jane F

Director

$10.00K (1)

—

+$10.00K

3,144

0.0272%

$5.25K

—

Glickman Mark A

Co-Chief Executive Officer

—

$2.17K (1) scheduled

−$2.17K

1,294

0.0112%

$2.16K

—

CARROLL J MARTIN

Director

—

106,864

0.9233%

$178.49K

+968.6%

ZIEGLER JOSEPH

Principal Financial Officer

—

7,500

0.0648%

$12.53K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Walker Marlan D

12 Apr 2023

Chief Executive Officer

Sold after exercise

1,170

$3.65

$4.28K

Donegan Michael C

26 Jan 2023

Prin. Fin. and Acctg. Officer

Sold after exercise

1,648

$5.08

$8.37K

Donegan Michael C

23 Jan 2023

Prin. Fin. and Acctg. Officer

Sold after exercise

1,302

$5.34

$6.95K

Donegan Michael C

6 Dec 2022

Interim CFO/CAO/VP of Finance

Sold after exercise

910

$4.78

$4.35K

Glickman Mark A

6 Dec 2022

Co-Chief Executive Officer

Sold after exercise

440

$4.92

$2.17K

Walker Marlan D

6 Dec 2022

General Counsel

Sold after exercise

1,048

$4.95

$5.18K

Bernick Brian

6 Dec 2022

Co-Chief Executive Officer

Sold after exercise

935

$4.92

$4.60K

Donegan Michael C

30 Nov 2021

CAO and VP of Finance

Sold after exercise

29,790

$0.54

$15.95K

Krassan Mitchell

3 Feb 2020

Chief Strategy Officer

Sold after exercise

300,000

$2.26

$676.92K

Finizio Robert G

20 Dec 2018

CEO

Sold after exercise

92,910

$3.63

$336.89K

Finizio Robert G

19 Dec 2018

CEO

Sold after exercise

92,000

$3.70

$340.22K

Milligan John C.K. IV

18 Dec 2018

President/Secretary

Sold after exercise

129,127

$3.64

$469.63K

Milligan John C.K. IV

17 Dec 2018

President/Secretary

Sold after exercise

129,000

$3.75

$483.75K

Bernick Brian

13 Dec 2018

Director

Sold after exercise indirect

91,910

$4.12

$378.58K

Bernick Brian

12 Dec 2018

Director

Sold after exercise indirect

91,400

$4.18

$381.96K

Finizio Robert G

7 Dec 2018

CEO

Sold after exercise

92,000

$4.60

$423.57K

Milligan John C.K. IV

6 Dec 2018

President/Secretary

Sold after exercise

129,000

$4.57

$589.53K

Cartwright Daniel A

6 Dec 2018

CFO

Sold after exercise

40,000

$4.57

$182.80K

Finizio Robert G

6 Dec 2018

CEO

Sold after exercise

92,000

$4.57

$420.62K

Milligan John C.K. IV

4 Dec 2018

President/Secretary

Sold after exercise

129,000

$4.98

$642.16K

Bernick Brian

3 Dec 2018

Director

Sold after exercise indirect

91,400

$5.18

$473.45K

Bernick Brian

30 Nov 2018

Director

Sold after exercise indirect

91,400

$4.96

$453.34K

Milligan John C.K. IV

29 Nov 2018

President/Secretary

Sold after exercise

129,128

$5.03

$650.03K

Milligan John C.K. IV

28 Nov 2018

President/Secretary

Sold after exercise

129,000

$4.89

$630.29K

Finizio Robert G

27 Nov 2018

CEO

Sold after exercise

92,000

$4.81

$442.06K

Finizio Robert G

26 Nov 2018

CEO

Sold after exercise

92,000

$4.86

$447.03K

Bernick Brian

20 Nov 2018

Director

Sold after exercise indirect

91,400

$4.74

$432.87K

Bernick Brian

19 Nov 2018

Director

Sold after exercise indirect

91,400

$4.75

$433.88K

Milligan John C.K. IV

15 Nov 2018

President/Secretary

Sold after exercise

129,000

$4.99

$643.58K

Milligan John C.K. IV

14 Nov 2018

President/Secretary

Sold after exercise

129,000

$4.82

$621.65K

Finizio Robert G

13 Nov 2018

CEO

Sold after exercise

92,000

$4.81

$442.43K

Finizio Robert G

12 Nov 2018

CEO

Sold after exercise

92,000

$4.73

$435.16K

Bernick Brian

9 Nov 2018

Director

Sold after exercise indirect

91,400

$4.83

$441.10K

Bernick Brian

8 Nov 2018

Director

Sold after exercise indirect

91,400

$4.93

$450.24K

Cartwright Daniel A

7 Nov 2018

CFO

Sold after exercise

40,000

$4.85

$194.00K

Finizio Robert G

26 Oct 2018

CEO

Sold after exercise

92,000

$5.12

$470.76K

Finizio Robert G

25 Oct 2018

CEO

Sold after exercise

92,000

$5.45

$501.31K

Milligan John C.K. IV

24 Oct 2018

President/Secretary

Sold after exercise

125,000

$5.37

$671.25K

Milligan John C.K. IV

23 Oct 2018

President/Secretary

Sold after exercise

125,000

$5.33

$666.25K

Bernick Brian

19 Oct 2018

Director

Sold after exercise indirect

91,400

$5.51

$503.61K

Bernick Brian

18 Oct 2018

Director

Sold after exercise indirect

91,400

$5.61

$512.75K

Finizio Robert G

12 Oct 2018

CEO

Sold after exercise

92,000

$5.45

$501.22K

Finizio Robert G

11 Oct 2018

CEO

Sold after exercise

92,000

$5.65

$519.62K

Milligan John C.K. IV

10 Oct 2018

President/Secretary

Sold after exercise

125,000

$5.76

$719.63K

Milligan John C.K. IV

9 Oct 2018

President/Secretary

Sold after exercise

125,000

$5.95

$743.13K

Bernick Brian

5 Oct 2018

Director

Sold after exercise indirect

91,400

$5.93

$542.00K

Bernick Brian

4 Oct 2018

Director

Sold after exercise indirect

91,400

$5.89

$538.35K

Bernick Brian

28 Sep 2018

Director

Sold after exercise indirect

91,400

$6.55

$598.58K

Bernick Brian

27 Sep 2018

Director

Sold after exercise indirect

91,400

$6.63

$605.98K

Milligan John C.K. IV

26 Sep 2018

President/Secretary

Sold after exercise

125,000

$6.78

$847.00K

Milligan John C.K. IV

25 Sep 2018

President/Secretary

Sold after exercise

125,000

$6.78

$847.25K

Finizio Robert G

21 Sep 2018

CEO

Sold after exercise

92,000

$6.67

$613.64K

Finizio Robert G

20 Sep 2018

CEO

Sold after exercise

92,000

$6.58

$605.36K

Bernick Brian

13 Sep 2018

Director

Sold after exercise indirect

91,400

$6.35

$579.93K

Bernick Brian

12 Sep 2018

Director

Sold after exercise indirect

91,400

$6.26

$571.71K

Milligan John C.K. IV

11 Sep 2018

President/Secretary

Sold after exercise

125,000

$6.13

$765.75K

Milligan John C.K. IV

10 Sep 2018

President/Secretary

Sold after exercise

125,000

$6.07

$758.13K

Finizio Robert G

7 Sep 2018

CEO

Sold after exercise

92,000

$6.22

$572.24K

Finizio Robert G

6 Sep 2018

CEO

Sold after exercise

92,000

$6.25

$575.00K

Show all 125 transactions →

TherapeuticsMD, Inc.

By person

Individual transactions

What was left out